04/15/2025
2:19 PM | Enfusion (Subject)
Somers Deirdre (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2025
8:21 PM | Enfusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
8:24 PM | Enfusion (Subject)
| Form 425 | |
04/02/2025
3:30 PM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
03/31/2025
5:09 AM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
03/31/2025
5:03 AM | Enfusion (Filer)
| Form DEFA14A | |
03/20/2025
3:10 PM | Enfusion (Filer)
| Form DEFM14A | |
03/07/2025
5:11 PM | Enfusion (Issuer)
Herring Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:13 PM | Enfusion (Issuer)
Gutowski Valeria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:14 PM | Enfusion (Issuer)
Pawar Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:15 PM | CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ENFN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter. |
03/07/2025
5:16 PM | Campobasso Matthew (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:17 PM | Bastone Bronwen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
2:12 PM | Enfusion (Subject)
Movchan Oleg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
5:17 PM | Bastone Bronwen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:18 PM | Campobasso Matthew (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:19 PM | Enfusion (Issuer)
Herring Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:20 PM | CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:20 PM | Enfusion (Issuer)
Pawar Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:21 PM | Enfusion (Issuer)
Gutowski Valeria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:16 PM | Enfusion (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/03/2025
2:42 PM | Enfusion (Subject)
Pawar Neal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
2:44 PM | Bastone Bronwen (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:05 PM | Enfusion (Issuer)
Herring Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | Bastone Bronwen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:06 PM | Campobasso Matthew (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:20 PM | Enfusion (Filer)
| Form DEFA14A | |
01/31/2025
3:28 PM | Enfusion (Subject)
Malherbe Investments LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/30/2025
5:08 AM | Enfusion (Filer)
| Form DEFA14A | |
01/15/2025
4:03 PM | Enfusion (Issuer)
Somers Deirdre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:52 PM | Enfusion (Subject)
FTV IV, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
01/14/2025
5:30 AM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
01/13/2025
4:11 PM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
01/13/2025
3:46 PM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
01/13/2025
3:48 PM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
01/13/2025
3:28 PM | Enfusion (Filer)
| Form DEFA14A | |
01/13/2025
2:15 PM | Clearwater Analytics Holdings, Inc. (Subject)
Enfusion (Filed by)
| Form 425 | |
01/13/2025
2:16 PM | Enfusion (Subject)
Somers Deirdre (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:43 AM | Clearwater Analytics Holdings, Inc. (Filed by)
Enfusion (Subject)
| Form 425 | |
01/13/2025
6:03 AM | Enfusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:16 PM | Campobasso Matthew (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
BREAKING: Trump Bans NVIDIA Chips to China (Ad) On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China.
That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953. There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, |
01/10/2025
3:18 PM | Enfusion (Issuer)
Gutowski Valeria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:19 PM | Enfusion (Issuer)
Herring Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:20 PM | CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
2:40 PM | Enfusion (Subject)
Herring Bradley (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
2:40 PM | Campobasso Matthew (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
2:43 PM | Bastone Bronwen (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
2:44 PM | Enfusion (Subject)
Movchan Oleg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
3:15 PM | Enfusion (Issuer)
Herring Bradley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
2:57 PM | Enfusion (Subject)
Herring Bradley (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
3:44 PM | Enfusion (Subject)
Pawar Neal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:52 PM | Enfusion (Issuer)
Pawar Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:21 PM | Enfusion (Subject)
Pawar Neal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
2:33 PM | Enfusion (Subject)
Pawar Neal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:15 PM | Enfusion (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
7:15 AM | Enfusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
6:13 PM | Enfusion (Subject)
Malherbe Investments LLC (Filed by)
| Form SC 13G/A | |
10/25/2024
3:30 PM | Enfusion (Subject)
LRA Ventures, LLC (Filed by)
| Form SC 13G/A | |
10/24/2024
3:15 PM | Campobasso Matthew (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
2:43 PM | Campobasso Matthew (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:15 PM | Bastone Bronwen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
2:16 PM | Bastone Bronwen (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
2:32 PM | BROWN CAPITAL MANAGEMENT LLC (Filed by)
Enfusion (Subject)
| Form SC 13G/A | |
08/06/2024
3:16 PM | Enfusion (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
6:45 AM | Enfusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
5:38 PM | Bastone Bronwen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:39 PM | Campobasso Matthew (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:40 PM | Enfusion (Issuer)
Gutowski Valeria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:19 PM | Bastone Bronwen (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
2:45 PM | Campobasso Matthew (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
2:50 PM | Bastone Bronwen (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
8:08 PM | Enfusion (Issuer)
LEIBOWITZ LAWRENCE E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
8:10 PM | DeRose Kathleen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
8:11 PM | Enfusion (Issuer)
Hauser Jan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
8:12 PM | Enfusion (Issuer)
Spellacy Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
8:14 PM | Enfusion (Issuer)
Somers Deirdre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
2:16 PM | Enfusion (Subject)
Somers Deirdre (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
2:36 PM | Bastone Bronwen (Reporting)
Enfusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:29 PM | Bastone Bronwen (Reporting)
Enfusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:45 AM | Enfusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:25 PM | Enfusion (Filer)
| Form ARS | |
04/26/2024
3:20 PM | Enfusion (Filer)
| Form DEFA14A | |
04/26/2024
3:15 PM | Enfusion (Filer)
| Form DEF 14A | |
